(Q36135619)

12 August 2017

1 reference

title

Does the breast cancer dollar make sense? (English)

1 reference

12 August 2017

R. J. Epstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1591070

12 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1591070

12 October 2022

publication date

1 January 1992

1 reference

European Journal of Cancer

12 August 2017

published in

1 reference

12 August 2017

volume

28

1 reference

12 August 2017

issue

2-3

1 reference

12 August 2017

page(s)

486-491

1 reference

The design of future cost-benefit studies

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Screening for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Management and survival of female breast cancer: results of a national survey by the American College of Surgeons

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

The value of mammography screening in women under age 50 years

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Mammography and palpable cancer of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Mammography in symptomatic breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Significance of ipsilateral breast tumour recurrence after lumpectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Locally recurrent carcinoma of the breast. Results of radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

The efficacy of delayed radiotherapy for locoregionally recurrent postmastectomy breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Cosmetic results following primary radiation therapy for early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Psychological effects of breast conserving therapy in comparison with radical mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

UICC Multidisciplinary Project on breast cancer. Management of early and advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Long-term psychological sequelae of mastectomy and breast conserving treatment for breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Psychosocial outcomes of breast cancer therapies: lumpectomy versus mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Breast conservation versus mastectomy: distress sequelae as a function of choice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Treatment of curable carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Prognostic assessment in node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Adjuvant therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Doctor-patient communication about breast cancer adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Effect of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: a clinical vignette study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Adjuvant therapy of node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Doctor-patient communication and ethical issues

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

How American oncologists treat breast cancer: an assessment of the influence of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Impact of chemotherapy of survival in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Survival of women with metastatic breast cancer at Yale from 1920 to 1980

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Quality of life and treatment of hormone resistant metastatic prostatic cancer. The EORTC Genito-Urinary Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Information and participation preferences among cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Auditing palliative cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Combination versus sequential single agent chemotherapy in advanced breast cancer: associations with metastatic sites and long-term survival. The Western Cancer Study Group and The Southeastern Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Side effects and emotional distress during cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Karnofsky memorial lecture. Conceptual and practical advances in the management of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

A phase III clinical trial comparing the combination cyclophosphamide, adriamycin, cisplatin with cyclophosphamide, 5-fluorouracil, prednisone in patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Comparison of CAF versus CMFP in metastatic breast cancer: analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Comparison of induction chemotherapies for metastatic breast cancer. An Eastern Cooperative Oncology Group Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

A randomized trial in postmenopausal patients with advanced breast cancer comparing endocrine and cytotoxic therapy given sequentially or in combination. The Australian and New Zealand Breast Cancer Trials Group, Clinical Oncological Society of Aust

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

1 reference

7 January 2021

A randomized comparative trial of combined versus alternating therapy with cytostatic drugs and high-dose medroxyprogesteron acetate in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

A comparison of two doses of tamoxifen (Nolvadex) in postmenopausal women with advanced breast cancer: 10 mg bd versus 20 mg bd.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Antagonism of chemotherapy-induced cytotoxicity for human breast cancer cells by antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Antagonism of aminoglutethimide and danazol in the suppression of serum free oestradiol in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Dose-response is alive and well

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Quality of life measurement in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Advanced breast cancer: high-dose chemotherapy and bone marrow autotransplants

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Dose-response in the treatment of breast cancer: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Analysis of dose intensity in doxorubicin-containing adjuvant chemotherapy in stage II and III breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

High-dose induction chemotherapy of metastatic breast cancer in protected environment: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Late intensification with high-dose melphalan and autologous bone marrow support in breast cancer patients responding to conventional chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Making cocktails versus making soup

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

c-erbB-2 proto-oncogene expression and its relationship to survival in gastric carcinoma: an immunohistochemical study on archival material.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Prognostic significance of her-2/neu expression in breast cancer and its relationship to other prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Follow-up of breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

An Assessment of Routine Liver Scanning in Patients With Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Chest X-ray survey in the follow-up of breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Preoperative and follow-up procedures on patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980084-X

7 January 2021

10.1016/S0959-8049(05)80084-X

Identifiers

DOI

1 reference

12 August 2017

1 reference